Get the Stockscreener App
1.41
2.92%
0.04
180 Life Sciences Corp Stock (ATNF) Forecast
The 180 Life Sciences Corp (ATNF) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $80.14, representing a +5,584% increase from the current price of $1.41. The highest analyst price target is $98.49, and the lowest is $61.79.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ATNF Price Target
Average 52.16
(+3,599% Upside)
Is 180 Life Sciences Corp (ATNF) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 38.54 | Neutral |
| STOCH(9,6) | 19.52 | Buy |
| STOCHRSI(14) | 36.09 | Neutral |
| MACD(12,26) | -0.1509 | Buy |
| ADX(14) | 11.22 | Neutral |
| William %R | -80.00 | Buy |
| CCI(14) | -59.87 | Neutral |
Buy: 3
Sell: 0
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.447
Sell
|
1.4338
Sell
|
| MA20 |
1.4985
Sell
|
1.5363
Sell
|
| MA50 |
1.8498
Sell
|
1.8364
Sell
|
| MA100 |
2.2689
Sell
|
2.075
Sell
|
| MA200 |
2.0694
Sell
|
2.6487
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ATNF could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 10 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on ATNF, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 38.54 indicates that ATNF is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 19.52 indicates that ATNF is oversold. This indicates that ATNF price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 36.09 indicates that ATNF is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 11.22 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -59.87 indicates that ATNF is still oversold but not to an extreme extent.
Long-term ATNF price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about 180 Life Sciences Corp financial reports and earnings history, 180 Life Sciences Corp (ATNF) stock could reach $37.34 by 2030, $194.85 by 2040 and $155.11 by 2050. See the projected annual prices until 2050 of the 180 Life Sciences Corp stock below:
- 180 Life Sciences Corp (ATNF) is expected to reach an average price of $42.96 in 2035, with a high prediction of $45.45 and a low estimate of $42.98. This indicates an $2,947% rise from the last recorded price of $1.41.
- 180 Life Sciences Corp (ATNF) stock is projected to chart a bullish course in 2040, with an average price target of $196.45, representing an $13,833% surge from its current level. The forecast ranges from a conservative $6.6027 to a sky-high $194.85.
- Our analysts predict 180 Life Sciences Corp (ATNF) to jump 9,566% by 2045, soaring from $116.87 to an average price of $136.28, potentially reaching $115.28. While $116.87 is the low estimate, the potential upside is significant.
- 180 Life Sciences Corp (ATNF) stock is expected to climb by 2050, reaching an average of $154.88, a $10,885% jump from its current level. However, a wide range of estimates exists, with high and low targets of $155.11 and $155.83, respectively, highlighting the market's uncertainty.
180 Life Sciences Corp Stock (ATNF) Year by Year Forecast
180 Life Sciences Corp Stock (ATNF) Price Forecast for 2025
180 Life Sciences Corp Stock (ATNF) is expected to reach an average price of $93.98 in 2025, with a high prediction of $186.90 and a low estimate of $1.066. This indicates an +6,565% rise from the last recorded price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $72.09 | $61.79 | $98.49 | +5,013% |
| April, 2025 | $71.66 | $62.19 | $99.33 | +4,982% |
| May, 2025 | $66.39 | $61.95 | $87.12 | +4,608% |
| June, 2025 | $91.72 | $34.45 | $92.52 | +6,405% |
| July, 2025 | $43.28 | $26.98 | $103.55 | +2,970% |
| August, 2025 | $19.61 | $11.21 | $46.23 | +1,291% |
| September, 2025 | $29.54 | $20.04 | $38.54 | +1,995% |
| October, 2025 | $27.51 | $18.71 | $34.37 | +1,851% |
| November, 2025 | $11.64 | $8.836 | $30.14 | +725.25% |
| December, 2025 | $4.4006 | $1.066 | $14.93 | +212.10% |
180 Life Sciences Corp Stock (ATNF) Price Forecast for 2026
The predicted value for 180 Life Sciences Corp (ATNF) in 2026 is set at an average of $10.45. Estimates vary from a peak of $20.13 to a trough of $0.7627, indicating an +640.88% surge from the present price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $8.13 | $1.0026 | $20.13 | +476.60% |
| February, 2026 | $10.78 | $0.7627 | $9.5607 | +664.35% |
| March, 2026 | $2.8086 | $7.0086 | $9.9066 | +99.19% |
| April, 2026 | $8.4633 | $4.7433 | $6.0453 | +500.23% |
| May, 2026 | $8.5166 | $8.78 | $7.4146 | +504.02% |
| June, 2026 | $13.58 | $11.63 | $12.06 | +863.12% |
| July, 2026 | $15.14 | $14.07 | $14.06 | +973.80% |
| August, 2026 | $13.43 | $13.83 | $12.69 | +852.48% |
| September, 2026 | $15.26 | $16.46 | $16.78 | +982.03% |
| October, 2026 | $16.27 | $16.39 | $15.98 | +1,054% |
| November, 2026 | $15.95 | $15.98 | $15.69 | +1,031% |
| December, 2026 | $15.55 | $15.47 | $15.50 | +1,003% |
180 Life Sciences Corp Stock (ATNF) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for 180 Life Sciences Corp (ATNF) is $10.34, with a high forecast of $15.46 and a low forecast of $5.2133. This indicates an +633.23% increase from the last price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $15.38 | $15.39 | $15.46 | +990.87% |
| February, 2027 | $14.39 | $14.70 | $15.12 | +920.61% |
| March, 2027 | $13.31 | $13.35 | $14.01 | +843.78% |
| April, 2027 | $12.51 | $12.51 | $13.04 | +786.99% |
| May, 2027 | $11.81 | $11.81 | $12.21 | +737.31% |
| June, 2027 | $10.78 | $10.81 | $11.41 | +664.68% |
| July, 2027 | $9.9094 | $9.9699 | $10.51 | +602.80% |
| August, 2027 | $9.1644 | $9.2041 | $9.6566 | +549.96% |
| September, 2027 | $8.1069 | $8.1144 | $8.9238 | +474.96% |
| October, 2027 | $7.3093 | $7.3273 | $7.8199 | +418.39% |
| November, 2027 | $6.3644 | $6.3966 | $7.0683 | +351.38% |
| December, 2027 | $5.2019 | $5.2133 | $6.126 | +268.93% |
180 Life Sciences Corp Stock (ATNF) Price Forecast for 2028
In 2028, 180 Life Sciences Corp (ATNF) is projected to reach an average price of $86.28, with a high projection of $172.39 and a low estimate of $0.1649. This indicates an +6,019% rise from the last price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.2426 | $1.2796 | $4.9496 | -11.87% |
| February, 2028 | $1.2119 | $0.6573 | $0.5419 | -14.05% |
| March, 2028 | $0.2286 | $0.5786 | $0.7093 | -83.79% |
| April, 2028 | $43.06 | $0.1649 | $46.02 | +2,954% |
| May, 2028 | $41.56 | $44.06 | $41.36 | +2,848% |
| June, 2028 | $25.70 | $31.10 | $40.70 | +1,723% |
| July, 2028 | $3.64 | $1.2293 | $60.69 | +158.16% |
| August, 2028 | $41.29 | $9.0233 | $121.62 | +2,828% |
| September, 2028 | $96.35 | $39.55 | $172.39 | +6,733% |
| October, 2028 | $80.61 | $46.54 | $132.41 | +5,617% |
| November, 2028 | $140.14 | $71.27 | $150.93 | +9,839% |
| December, 2028 | $95.40 | $93.40 | $145.20 | +6,666% |
180 Life Sciences Corp Stock (ATNF) Price Forecast for 2029
The 2029 price forecast for 180 Life Sciences Corp Stock (ATNF) is $50.71 on average, with a high prediction of $99.52 and a low estimate of $1.896. This represents an +3,496% increase from the previous price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $27.62 | $16.52 | $99.52 | +1,859% |
| February, 2029 | $33.19 | $22.19 | $59.59 | +2,254% |
| March, 2029 | $32.25 | $23.98 | $60.65 | +2,187% |
| April, 2029 | $27.11 | $24.91 | $49.84 | +1,823% |
| May, 2029 | $55.83 | $1.896 | $56.63 | +3,860% |
| June, 2029 | $13.50 | $6.30 | $67.90 | +857.17% |
| July, 2029 | $16.24 | $3.1614 | $14.56 | +1,052% |
| August, 2029 | $3.3159 | $3.7159 | $9.7119 | +135.17% |
| September, 2029 | $6.4546 | $1.9853 | $2.0786 | +357.77% |
| October, 2029 | $19.13 | $8.7239 | $9.5279 | +1,257% |
| November, 2029 | $33.47 | $22.66 | $20.56 | +2,274% |
| December, 2029 | $25.41 | $29.91 | $33.60 | +1,702% |
180 Life Sciences Corp Stock (ATNF) Price Forecast for 2030
180 Life Sciences Corp Stock (ATNF) is expected to reach an average price of $31.74 in 2030, with a high forecast of $37.54 and a low forecast of $25.94. This signifies an +2,151% surge from the last price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $38.52 | $25.94 | $37.34 | +2,632% |
| February, 2030 | $29.62 | $33.82 | $37.41 | +2,001% |
| March, 2030 | $32.76 | $31.09 | $28.56 | +2,223% |
| April, 2030 | $33.05 | $33.96 | $32.83 | +2,244% |
| May, 2030 | $37.36 | $34.03 | $35.85 | +2,550% |
| June, 2030 | $37.03 | $37.15 | $36.38 | +2,526% |
| July, 2030 | $35.12 | $35.52 | $36.68 | +2,391% |
| August, 2030 | $38.13 | $37.91 | $37.54 | +2,604% |
| September, 2030 | $36.42 | $36.57 | $35.87 | +2,483% |
| October, 2030 | $34.61 | $34.84 | $35.57 | +2,355% |
| November, 2030 | $33.35 | $33.43 | $33.94 | +2,265% |
| December, 2030 | $32.37 | $32.48 | $32.83 | +2,196% |
0.51%
2.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):